Search Results - "Blaakær, J"

Low attendance by non-native women to human papillomavirus vaccination and cervical cancer screening – A Danish nationwide register-based cohort study by Badre-Esfahani, S., Larsen, MB, Seibæk, L., Petersen, LK, Blaakær, J., Andersen, B.

“…Cervical cancer is preventable through human papillomavirus vaccination and cervical cancer screening. However, possibly due to systemic, individual (e.g. low…”
Get full text

Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer by Faber, M. T., Jensen, A., Frederiksen, K., Glud, E., Høgdall, E., Høgdall, C., Blaakær, J., Kjær, S. K.

“…Purpose: Oral contraceptive use decreases the risk of ovarian cancer, but no previous studies have assessed the impact of cumulative intake of estrogen and…”
Get full text

Influence of Prior Psychiatric Disorders on the Treatment Course of Gynaecological Cancer – A Nationwide Cohort Study by Iachina, M., Ljungdalh, P.M., Sørensen, R.G., Kaerlev, L., Blaakær, J., Trosko, O., Qvist, N., Nørgård, B.M.

“…To examine the influence of pre-existing psychiatric disorder on the choice of treatment in patients with gynaecological cancer. The analyses were based on all…”
Get full text

Expanding the upper age limit for cervical cancer screening: a protocol for a nationwide non-randomised intervention study by Tranberg, Mette, Petersen, Lone Kjeld, Elfström, Klara Miriam, Hammer, Anne, Blaakær, Jan, Bennetsen, Mary Holten, Jensen, Jørgen Skov, Andersen, Berit

“…IntroductionCervical cancer screening ceases between the ages of 60 and 65 in most countries. Yet, a relatively high proportion of cervical cancers are…”
Get full text

Is it possible to define an optimal time for chemotherapy after surgery for ovarian cancer? by Lydiksen, L, Jensen-Fangel, S, Blaakaer, J

“…Abstract Objective The aims of this study are to investigate the actual time from primary surgery for epithelial ovarian cancer (OC) to initiation of…”
Get full text

Increased risk of ovarian cancer in integrin β3 Leu33Pro homozygotes by Bojesen, S E, Kjær, S K, Høgdall, E V S, Thomsen, B L, Høgdall, C K, Blaakær, J, Tybjærg-Hansen, A, Nordestgaard, B G

“…We previously demonstrated that integrin β3 Leu33Pro homozygotes have an increased risk of cancer, possibly most pronounced for ovarian cancer. We now test the…”
Get full text

Do risk factors for epithelial ovarian cancer have an impact on prognosis? Focus on previous pelvic surgery and reproductive variables by Kjaerbye-Thygesen, A, Frederiksen, K, Høgdall, E V, Høgdall, C K, Blaakaer, J, Kjaer, S Krüger

“…The prognostic impact of risk factors for ovarian cancer development is sparsely explored, but previous sterilisation has been shown to have a negative impact…”
Get more information

Hoping for the best, preparing for the worst: the lived experiences of women undergoing ovarian cancer surgery by SEIBAEK, L., PETERSEN, L.K., BLAAKAER, J., HOUNSGAARD, L.

“…SEIBAEK L., PETERSEN L.K., BLAAKAER J. & HOUNSGAARD L. (2012) European Journal of Cancer Care21, 360–371 Hoping for the best, preparing for the worst: the…”
Get full text

Improved survival of patients with ovarian cancer in Northern Denmark, 1985-2004 by Tetsche, M S, Nørgaard, M, Jacobsen, J, Andersen, E S, Lundorff, P, Blaakaer, J, Sørensen, H T

“…Ovarian cancer is a serious disease with a high mortality. Our aim was to examine changes in the survival of patients with ovarian cancer in Northern Denmark…”
Get more information

The impact of frailty screening and geriatric assessment in older patients with ovarian cancer by Oreskov, J.O., Lund, C., Cobián, C., Herrstedt, J., Blaakær, J., Jørgensen, T., Ryg, J., Høgdall, C., Schnack, T.

Get full text

Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder by Mattiasson, A., Blaakaer, J., Høye, K., Wein, A.J.

“…OBJECTIVES To compare the efficacy of tolterodine plus simplified bladder training (BT) with tolterodine alone in patients with an overactive bladder. PATIENTS…”
Get full text

HPV self-sampling in cervical cancer screening: the effect of different invitation strategies in various socioeconomic groups - a randomized controlled trial by Tranberg, Mette, Bech, Bodil Hammer, Blaakær, Jan, Jensen, Jørgen Skov, Svanholm, Hans, Andersen, Berit

“…Participation in cervical cancer screening varies by socioeconomic status. The aims were to assess if offering human papilloma virus (HPV) self-sampling kits…”
Get full text

Systemic interferon alpha-2b increases the cure rate in laser treated patients with multiple persistent genital warts: a placebo-controlled study by Petersen, C S, Bjerring, P, Larsen, J, Blaakaer, J, Hagdrup, H, From, E, Obergaard, L

“…Systemic treatment modalities for eradication of multiple therapy resistant genital warts are so far not available. In this study laser treated patients with…”
Get full text

Non-Adherence To Childhood HPV Vaccination Is Associated With Non-Participation In Cervical Cancer Screening - A Nationwide Danish Register-Based Cohort Study by Badre-Esfahani, Sara, Larsen, Mette Bach, Seibæk, Lene, Petersen, Lone Kjeld, Blaakær, Jan, Støvring, Henrik, Andersen, Berit

“…The combination of organized cervical cancer screening and childhood HPV vaccination programs has the potential to eliminate cervical cancer in the future…”
Get full text

Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors by Begum, F.D, Høgdall, E, Kjaer, S.K, Blaakaer, J, Christensen, I.J, Christensen, L, Høgdall, C

“…Abstract Objectives To improve the poor survival in ovarian cancer (OC) patients, the research has been focused on new OC markers. One aim is to find markers…”
Get full text

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer by Quaye, L, Song, H, Ramus, S J, Gentry-Maharaj, A, Høgdall, E, DiCioccio, R A, McGuire, V, Wu, A H, Van Den Berg, D J, Pike, M C, Wozniak, E, Doherty, J A, Rossing, M A, Ness, R B, Moysich, K B, Høgdall, C, Blaakaer, J, Easton, D F, Ponder, B A J, Jacobs, I J, Menon, U, Whittemore, A S, Krüger-Kjaer, S, Pearce, C L, Pharoah, P D P, Gayther, S A

“…Low–moderate risk alleles that are relatively common in the population may explain a significant proportion of the excess familial risk of ovarian cancer (OC)…”
Get full text

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer by QUAYE, L, SONG, H, WOZNIAK, E, DOHERTY, J. A, ROSSING, M. A, NESS, R. B, MOYSICH, K. B, HØGDALL, C, BLAAKAER, J, EASTON, D. F, PONDER, Baj, JACOBS, I. J, RAMUS, S. J, MENON, U, WHITTEMORE, A. S, KRÜGER-KJAER, S, PEARCE, C. L, PHAROAH, Pdp, GAYTHER, S. A, GENTRY-MAHARAJ, A, HØGDALL, E, DICIOCCIO, R. A, MCGUIRE, V, WU, A. H, VAN DEN BERG, D. J, PIKE, M. C

Get full text

PIN50 - COST-EFFECTIVENESS OF GENDER-NEUTRAL NINE-VALENT HPV VACCINATION IN DENMARK by Olsen, J., le Fevre, T., Blaakaer, J.

Get full text

Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer by Glud, Eva, Kjaer, Susanne K, Thomsen, Birthe L, Høgdall, Claus, Christensen, Lise, Høgdall, Estrid, Bock, Johannes E, Blaakaer, Jan

“…The association between menopausal hormone therapy (HT) and risk of ovarian cancer is as yet equivocal, and the effect of estrogen and estrogen-progestogen…”
Get more information

Value of a catch-up HPV test in women aged 65 and above: A Danish population-based nonrandomized intervention study by Tranberg, Mette, Petersen, Lone Kjeld, Hammer, Anne, Elfström, Miriam, Blaakær, Jan, Jørgensen, Susanne Fogh, Bennetsen, Mary Holten, Jensen, Jørgen Skov, Andersen, Berit

“…High-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical cancer screening test due to superior sensitivity, but in most…”
Get full text